StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.54−0.50 (-5.53%)

Close on Nov 16, 2026Market cap $297.90MP/E –Yield –

Benitec Biopharma ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Benitec Biopharma's ebitda for the twelve months ending Jun 30, 2026 was -$51.13M. For fiscal 2026 it was -$51.13M. The highest annual figure on record is $2.74M in fiscal 2019.

Annual ebitda

PeriodPeriod endValueChange
FY2026Jun 30, 2026-$51.13M–
FY2025Jun 30, 2025-$41.70M–
FY2024Jun 30, 2024-$22.40M–
FY2023Jun 30, 2023-$18.95M–
FY2022Jun 30, 2022-$17.69M–
FY2021Jun 30, 2021-$13.37M–
FY2020Jun 30, 2020-$8.09M-395.2%
FY2019Jun 30, 2019$2.74M–

Quarterly ebitda

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026-$14.41M–
Q3 FY2026CQ1 2026Mar 31, 2026-$13.57M–
Q2 FY2026CQ4 2025Dec 31, 2025-$13.36M–
Q1 FY2026CQ3 2025Sep 30, 2025-$9.79M–
Q4 FY2025CQ2 2025Jun 30, 2025-$9.82M–
Q3 FY2025CQ1 2025Mar 31, 2025-$15.32M–
Q2 FY2025CQ4 2024Dec 31, 2024-$10.79M–
Q1 FY2025CQ3 2024Sep 30, 2024-$5.77M–
Q4 FY2024CQ2 2024Jun 30, 2024-$5.52M–
Q3 FY2024CQ1 2024Mar 31, 2024-$4.12M–
Q2 FY2024CQ4 2023Dec 31, 2023-$6.91M–
Q1 FY2024CQ3 2023Sep 30, 2023-$5.86M–
Q4 FY2023CQ2 2023Jun 30, 2023-$4.53M–
Q3 FY2023CQ1 2023Mar 31, 2023-$4.31M–
Q2 FY2023CQ4 2022Dec 31, 2022-$5.57M–
Q1 FY2023CQ3 2022Sep 30, 2022-$4.54M–
Q4 FY2022CQ2 2022Jun 30, 2022-$4.73M–
Q3 FY2022CQ1 2022Mar 31, 2022-$3.41M–
Q2 FY2022CQ4 2021Dec 31, 2021-$4.78M–
Q1 FY2022CQ3 2021Sep 30, 2021-$4.77M–
Q4 FY2021CQ2 2021Jun 30, 2021-$3.80M–
Q3 FY2021CQ1 2021Mar 31, 2021-$3.73M–
Q2 FY2021CQ4 2020Dec 31, 2020-$3.19M–
Q1 FY2021CQ3 2020Sep 30, 2020-$2.65M–
Q4 FY2020CQ2 2020Jun 30, 2020-$2.85M–
Q3 FY2020CQ1 2020Mar 31, 2020-$2.06M–
Q2 FY2020CQ4 2019Dec 31, 2019-$2.06M–
Q1 FY2020CQ3 2019Sep 30, 2019-$1.12M–

More Benitec Biopharma figures

See a number that looks wrong?